PETS — PetMed Express Cashflow Statement
0.000.00%
Last trade - 00:00- $34.68m
- -$20.05m
- $226.97m
- 80
- 80
- 33
- 71
Annual cashflow statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30.6 | 21.1 | 5.14 | -7.46 | -6.27 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.44 | 4.71 | 6.83 | 7.19 | -5.02 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.3 | -9.71 | 13.9 | -2.76 | 3.72 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 40.1 | 18.5 | 27.8 | 4.32 | 4.72 |
| Capital Expenditures | -2.43 | -1.75 | -5.26 | -4.51 | -5.11 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -5 | -36.2 | 0 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.43 | -1.75 | -10.3 | -40.7 | -5.11 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -22.7 | -24.4 | -24.5 | -12.4 | -0.181 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15 | -7.64 | -6.99 | -48.8 | -0.576 |